Genflow Biosciences plc (LON:GENF) (OTCQB:GENFF) is a UK-based biotech company with R&D facilities in Belgium and a U.S. office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Managed by an experienced team with decades of experience in the pharmaceutical and biotechnology sectors, the company is optimistic that development programs will continue at pace in the next 24 months.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Biopark Gosselies Rue Auguste Piccard 48, Gosselies,6041,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- genflowbio.com
- HQ
- Gosselies
Genflow Biosciences (Lon:genf) (Otcqb:genff) Questions
Genflow Biosciences (Lon:Genf) (Otcqb:Genff)'s website is genflowbio.com
Genflow Biosciences (Lon:Genf) (Otcqb:Genff)'s LinkedIn profile is https://be.linkedin.com/company/genflow-biosciences
Genflow Biosciences (Lon:Genf) (Otcqb:Genff) has
5 employees.
View email and phone details for 5
employees at Genflow Biosciences (Lon:Genf) (Otcqb:Genff).
Genflow Biosciences (Lon:Genf) (Otcqb:Genff)'s industry is
Biotechnology Research
Genflow Biosciences (Lon:Genf) (Otcqb:Genff)'s top competitors are
Genflow,
Clock.bio,
Altos Labs,
Rejuvenate Bio,
Brainstorm Cell Therapeutics,
Shift Bioscience,
Geneventiv Therapeutics, Inc.,
Cellistic,
Revatis,
Neuvasq Biotechnologies.
Genflow Biosciences (Lon:Genf) (Otcqb:Genff)'s categories are Biotechnology Research
Genflow Biosciences (Lon:Genf) (Otcqb:Genff)'s founding year is 2020
